Fresenius Kidney Care Achieves Strongest Quality Ratings to Date
Demonstrates Industry Leadership and Commitment to Patient Experience
WALTHAM, Mass. Ģý Oct. 31, 2019 Ģý, a division of Ģý North America (FMCNA) and the nationĢýs leading network of dialysis facilities, has continued to improve clinical quality as measured by the U.S. governmentĢýs Five-Star Rating System. The latest results reflect the companyĢýs strongest performance to date and their ongoing commitment to improved quality and patient experience.
More than 94 percent of Fresenius Kidney Care centers were rated three stars and above for Quality of Patient Care, and the company also achieved the highest percentage and number of four and five star clinics to date. A total of 762 Fresenius Kidney Care centers achieved the highest five star rating in clinical quality, up from 658 last year.
ĢýEvery day, our care team provides superior care to people living with kidney disease, and these results are a testament to their hard work and commitment,Ģý said Mike Asselta, President of Fresenius Kidney Care. ĢýI am grateful for the physicians, nurses, social workers, dietitians, patient care technicians, and other support team members in our clinics who are dedicated to improving the quality of our patientsĢý lives. These results demonstrate that our care givers deliver the best care in the industry.Ģý
The Centers for Medicare and Medicaid Services (CMS) assigns one to five stars to each dialysis center annually based on a series of measurements around clinical performance and patient outcomes. The public results are published on the.
ĢýThese ratings reflect the collective work across all providers in the industry to continue to improve upon quality of care and patient experience, whether large or small, for-profit or non-profit,Ģý said Dr. Jeffrey Hymes, Chief Medical Officer for Fresenius Kidney Care and SVP of Clinical and Scientific Affairs for FMCNA. ĢýOur exceptional Five-Star ratings reflect our continued success in reducing infections and hospitalizations for our patients as well as other key quality metrics.Ģý
Each year, Fresenius Kidney Care introduces its own annual Quality Agenda, a collaborative initiative to organize clinical care around core quality measures. The nationwide campaign revisits fundamentals of safety and quality while highlighting new innovations. This includes building a culture of patient safety; an antibiotic stewardship and infection control initiative; a vascular access program; precision medicine and analytics efforts; medication management and reconciliation; and other initiatives that focus on dialysis care fundamentals.
Additionally, the company hasin the 5-Diamond Patient Safety Program, with nearly 100 percent of facilities achieving 5-Diamond status this past year.
Ģý Fresenius Kidney Care
Fresenius Kidney Care, a division ofĢý North America(FMCNA), provides dialysis treatment and support services to more than 190,000 people with kidney disease every year whether in their own homes or at more than 2,400 facilities nationwide. Fresenius Kidney CareĢýs dedicated teams help address the physical and emotional aspects of kidney disease through personalized care, education and lifestyle support services. For more information about Fresenius Kidney Care, visit.
Ģý Ģý North America
Ģý North America is the premier healthcare company focused on providing the highest quality care to people with renal and other chronic conditions. Through its industry-leading network of dialysis facilities, outpatient cardiac and vascular labs and urgent care centers, Ģý North America provides coordinated health care services at pivotal care points for hundreds of thousands of chronically ill customers throughout the continent. As the worldĢýs largest fully integrated renal company, it offers specialty pharmacy and laboratory services, and manufactures and distributes the most comprehensive line of dialysis equipment, disposable products and renal pharmaceuticals. For more information, visit the FMCNA website at.
